Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

about

Nanoformulations for combination or cascade anticancer therapy.Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances

P2860

Q39380111-C3961D48-51B7-457A-825B-71B41D80B1D5 Q57372130-DE982D30-5729-4E35-9476-7AA58C28EAF9

P2860

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

Item

http://www.wikidata.org/entity/Q38943053

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

@en

type

Item

label

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

@en

prefLabel

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

@en

P1476

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

@en

P2093

Bizhan Malaekeh-Nikouei

http://www.w3.org/2001/XMLSchema#string

Legha Ansari

http://www.w3.org/2001/XMLSchema#string

Mohammad Yahya Hanafi-Bojd

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical and clinical development of siRNA-based therapeutics

A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent

Nanocarriers as an emerging platform for cancer therapy

A DNA transporter based on mesoporous silica nanospheres mediated with polycation poly(allylamine hydrochloride) coating on mesopore surface.

pH- and photo-switched release of guest molecules from mesoporous silica supports.

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

The golden age: gold nanoparticles for biomedicine.

EPR: Evidence and fallacy.

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Nanoparticles in medicine: therapeutic applications and developments.

P304

649-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE-2016-0045

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27582236

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

about

P2860

P2860

Codelivery of anticancer drugs and siRNA by mesoporous silica nanoparticles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921